Publications by authors named "James Mond"

Claim this Profile
I
In-vivo and human evidence for potential efficacy of therapeutic polyclonal RSV neutralizing antibodies for palivizumab-resistant RSV infections.
Kacy A Ramirez, James Mond, Jesse Papenburg, Guy Boivin, Brian E Gilbert

Virology· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies.
Jérémy Manry, Paul Bastard, Adrian Gervais, Tom Le Voyer, Jérémie Rosain, James Mond

Proc Natl Acad Sci U S A· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Epstein-Barr virus (EBV) hyperimmune globulin isolated from donors with high gp350 antibody titers protect humanized mice from challenge with EBV" [Virology 561 (2021) 80-86].
JungHyun Kim, Wei Bu, Sohtaro Mine, Zeshan Tariq, Hanh Nguyen, James Mond

Virology· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies.
Jeremy Manry, Paul Bastard, Adrian Gervais, Tom Le Voyer, Jérémie Rosain, James Mond

Res Sq· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epstein-Barr virus (EBV) hyperimmune globulin isolated from donors with high gp350 antibody titers protect humanized mice from challenge with EBV.
JungHyun Kim, Wei Bu, Sohtaro Mine, Zeshan Tariq, Hanh Nguyen, James Mond

Virology· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoantibodies neutralizing type I IFNs are present in 4% of uninfected individuals over 70 years old and account for 20% of COVID-19 deaths.
Paul Bastard, Adrian Gervais, Tom Le Voyer, Jérémie Rosain, Quentin Philippot, James Mond

Sci Immunol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Manufacturing process optimization of ADMA Biologics' intravenous immunoglobulin products, BIVIGAM and ASCENIV™.
Richard L Wasserman, Daniel Garcia, Benjamin N Greener, Kaitlin Kestenberg, Adam Pinkert, James Mond

Immunotherapy· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RI-002, an intravenous immunoglobulin containing high titer neutralizing antibody to RSV and other respiratory viruses for use in primary immunodeficiency disease and other immune compromised populations.
Richard L Wasserman, Benjamin N Greener, James Mond

Expert Rev Clin Immunol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel synthetic (poly)glycerolphosphate-based antistaphylococcal conjugate vaccine.
Quanyi Chen, Jay Dintaman, Andrew Lees, Goutam Sen, David Schwartz, James J Mond

Infect Immun· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel tetrameric gp350 1-470 as a potential Epstein-Barr virus vaccine.
Xinle Cui, Zhouhong Cao, Goutam Sen, Gouri Chattopadhyay, Deborah H Fuller, James J Mond

Vaccine· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized study of a monoclonal antibody (pagibaximab) to prevent staphylococcal sepsis.
Leonard E Weisman, Helen M Thackray, Robin H Steinhorn, William F Walsh, Herbert A Lassiter, James J Mond

Pediatrics· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1/2 double-blind, placebo-controlled, dose escalation, safety, and pharmacokinetic study of pagibaximab (BSYX-A110), an antistaphylococcal monoclonal antibody for the prevention of staphylococcal bloodstream infections, in very-low-birth-weight neonates.
Leonard E Weisman, Helen M Thackray, Joseph A Garcia-Prats, Mirjana Nesin, Joseph H Schneider, James J Mond

Antimicrob Agents Chemother· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lysostaphin eradicates established Staphylococcus aureus biofilms in jugular vein catheterized mice.
John F Kokai-Kun, Tanya Chanturiya, James J Mond

J Antimicrob Chemother· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and pharmacokinetics of a chimerized anti-lipoteichoic acid monoclonal antibody in healthy adults.
Leonard E Weisman, Gerald W Fischer, Helen M Thackray, Karen E Johnson, Richard F Schuman, James J Mond

Int Immunopharmacol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lysostaphin as a treatment for systemic Staphylococcus aureus infection in a mouse model.
John F Kokai-Kun, Tanya Chanturiya, James J Mond

J Antimicrob Chemother· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of IsaA and SceD, two putative lytic transglycosylases of Staphylococcus aureus.
Melanie R Stapleton, Malcolm J Horsburgh, Emma J Hayhurst, Lynda Wright, Ing-Marie Jonsson, James J Mond

J Bacteriol· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Staphylococcus aureus surface protein IsdA mediates resistance to innate defenses of human skin.
Simon R Clarke, Ramlan Mohamed, Li Bian, Alexander F Routh, John F Kokai-Kun, James J Mond

Cell Host Microbe· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Catalase (KatA) and alkyl hydroperoxide reductase (AhpC) have compensatory roles in peroxide stress resistance and are required for survival, persistence, and nasal colonization in Staphylococcus aureus.
Kate Cosgrove, Graham Coutts, Ing-Marie Jonsson, Andrej Tarkowski, John F Kokai-Kun, James J Mond

J Bacteriol· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of antigenic components of Staphylococcus epidermidis expressed during human infection.
Mohammad R Pourmand, Simon R Clarke, Richard F Schuman, James J Mond, Simon J Foster

Infect Immun· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of in vivo-expressed antigens of Staphylococcus aureus and their use in vaccinations for protection against nasal carriage.
Simon R Clarke, Kirsten J Brummell, Malcolm J Horsburgh, Philip W McDowell, Sharifah A Syed Mohamad, James J Mond

J Infect Dis· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The critical DNA flanking sequences of a CpG oligodeoxynucleotide, but not the 6 base CpG motif, can be replaced with RNA without quantitative or qualitative changes in Toll-like receptor 9-mediated activity.
Goutam Sen, Michael Flora, Gouri Chattopadhyay, Dennis M Klinman, Andrew Lees, James J Mond

Cell Immunol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Industrial-scale production and purification of a heterologous protein in Lactococcus lactis using the nisin-controlled gene expression system NICE: the case of lysostaphin.
Igor Mierau, Peter Leij, Iris van Swam, Barry Blommestein, Esther Floris, James Mond

Microb Cell Fact· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of the Lactococcus lactis nisin-controlled gene expression system NICE for industrial applications.
Igor Mierau, Kees Olieman, James Mond, Eddy J Smid

Microb Cell Fact· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended nasal residence time of lysostaphin and an anti-staphylococcal monoclonal antibody by delivery in semisolid or polymeric carriers.
Scott Walsh, John Kokai-Kun, Anjali Shah, James Mond

Pharm Res· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proliferative assays for B cell function.
James J Mond, Mark Brunswick

Curr Protoc Immunol· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis